TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)

Clinical trial NCT03103412 · COMPLETED

Trial details

NCT number: NCT03103412
Sponsor: Theravance Biopharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects

Start date: 2017-05-04
Primary completion: 2017-11-08
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.